Fixnip LTD is an Israeli medical device startup that revives the field of breast augmentation through the FixNip Nipple Reconstruction Implant (NRI). FixNip offers women who have had breast cancer surgery and their physicians a revolutionary, minimally invasive, and safe approach for nipple areola reconstruction. The NRI provides breast cancer survivors with natural nipple reconstruction and helps them regain self-confidence. Important features of a reconstructed nipple are overall symmetry and a durable and sturdy vertical projection. FixNip has conducted and received regulatory approval with three clinical studies in France, Israel, and Italy with 70 successful implants. Additionally, ove...

Read More

Fixnip LTD is an Israeli medical device startup that revives the field of breast augmentation through the FixNip Nipple Reconstruction Implant (NRI). FixNip offers women who have had breast cancer surgery and their physicians a revolutionary, minimally invasive, and safe approach for nipple areola reconstruction. The NRI provides breast cancer survivors with natural nipple reconstruction and helps them regain self-confidence. Important features of a reconstructed nipple are overall symmetry and a durable and sturdy vertical projection. FixNip has conducted and received regulatory approval with three clinical studies in France, Israel, and Italy with 70 successful implants. Additionally, over 230 commercial cases demonstrate proven safety and high patient satisfaction among breast cancer survivors. FixNip and some of its officers' plan to move its headquarters to Texas, initiate a pivotal clinical study at MD Anderson Cancer Center, expand to additional sites, and enroll 105 patients. The company intends to scale up manufacturing in Texas and expand its sales and marketing efforts. FixNip's CPRIT application aligns with CPRIT priorities and survivorship goals in the Texas Cancer Plan.

Read Less